Specifically, we have studied the effect of AZD5363 on the levels of pro‐angiogenic proteins VEGF and hypoxia‐inducible factor 1‐alpha (HIF‐1α) and the subsequent impact of any alteration on tumour vascularity and oxygenation. The gene discussed is HIF1A; the disease is neoplasm.